ON-Q PainBuster, which was ON-Q (Classic), Provides the Same Trusted Pain Relief Following Surgery, Helping Patients Get Back to Their Normal Lives Faster

LAKE FOREST, Calif., Jan 21, 2004 (BUSINESS WIRE) --

I-Flow Corporation, (NASDAQ: IFLO) today announced that it has added the name PainBuster to the lead product in its ON-Q(R) post-surgical pain relief brand. ON-Q PainBuster(R) (formerly ON-Q (Classic)) will continue to provide a trusted option for targeted pain relief that helps patients get back to their normal lives faster after surgery by dependably delivering a non-narcotic numbing medication directly to an incision site. By adding the PainBuster name to ON-Q, existing PainBuster users will quickly know that the product they have been using is now available from I-Flow as ON-Q PainBuster. ON-Q is the most widely-used choice among post-surgical pain relief devices in a potential market that is estimated to exceed $2 billion in the U.S. alone.

ON-Q PainBuster is a simple yet elegant device that consists of a small, high-tech balloon pump that holds local anesthetic (a pain-numbing medicine) and delivers it through a tiny, specially-designed tube (catheter) directly into the surgical site. The proprietary ON-Q Soaker Catheter is designed to provide more even distribution of local anesthetic over a wider area than a fenestrated catheter, because of its patented wicking capabilities.

"We are excited to get the PainBuster name back from a licensing partner and are making this change to our flagship product to better serve former PainBuster customers directly. We are also encouraged that other companies are beginning to recognize the value of this therapy for patients and the resulting market potential," said Donald M. Earhart, president and CEO of I-Flow Corporation. "While we still believe that our unique technology, programs and sales and marketing efforts have propelled us to become the number one choice in this market, we also realize that additional entries into this space will accelerate adoption of this novel therapeutic approach."

ON-Q PainBuster will deliver narcotic-free pain relief for many surgeries, including: cesarean sections, hysterectomies, knee replacements, mastectomies, cardio-vascular/thoracic surgeries, foot and ankle surgeries and many cosmetic surgeries. Currently, 26 studies of the use of ON-Q have been completed and published and yet another body of research is underway investigating the use of ON-Q in additional areas such as pediatrics and wound healing.

For more information about ON-Q, visit www.AskYourSurgeon.com or call 800-448-3569.

About I-Flow Corporation

I-Flow Corporation (www.iflo.com) designs, develops and markets technically advanced drug delivery systems that are redefining the standard of care by providing life enhancing, cost effective solutions for pain relief.

Certain disclosures made by the Company in this press release and in other reports and statements released by the Company are and will be forward-looking in nature, such as comments that express the Company's opinions about trends and factors that may impact future operating results. Disclosures that use words such as the Company "believes," "anticipates," or "expects" or use similar expressions are intended to identify forward-looking statements. Forward-looking statements are subject to certain risks and uncertainties, which could cause actual results to differ from those expected, and readers are cautioned not to place undue reliance on these forward-looking statements. The Company undertakes no obligation to republish revised forward-looking statements to reflect the occurrence of unanticipated events. Readers are also urged to carefully review and consider the various disclosures made by the Company in this release which seek to advise interested parties of the risks and other factors that affect the Company's business, as well as in the Company's periodic reports on Forms 10-K, 10-Q, and 8-K filed with the Securities and Exchange Commission. The risks affecting the Company's business include reliance on the success of the home health care industry, the Company's success in pursuing its direct sales strategy, the reimbursement system currently in place and future changes to that system, competition in the industry, economic and political conditions in foreign countries, currency exchange rates, inadequacy of booked reserves, technological changes and product availability. Any such forward-looking statements, whether made in this release or elsewhere, should be considered in context with the various disclosures made by the Company about its business.

SOURCE: I-Flow Corporation

Schwartz Communications
Wendy Williams or Brian Bogie, 781-684-0770
i-flow@schwartz-pr.com
or
I-Flow Corporation
Orlando Rodrigues, 949-206-2619
orlando.rodrigues@i-flowcorp.com
      

Customize your Business Wire news & multimedia to match your needs.
Get breaking news from companies and organizations worldwide.
Logon for FREE today at www.BusinessWire.com.